MeSH D016867 - immunocompromised host
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/1
Phase 3
0%0/8
Approved: 0Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use